BEKHealth Corp
Funding rounds
5 counted as startup funding. Open the number of investors for the round's details.
| Month | Raised | Raise | Size | Investors | Sold | Filing |
|---|---|---|---|---|---|---|
| Oct 2026 | $5 M | No. 5 | $2 to $10 million | equity | SEC | |
| Sep 2024 | $4 M | No. 4 | $2 to $10 million | equity | SEC | |
| Nov 2023 | $2 M | No. 3 | Under $2 million | equity | SEC | |
| Feb 2023 | $5 M | No. 2 | $2 to $10 million | equity | SEC | |
| Jun 2021 | $5 M | No. 1 | $2 to $10 million | equity | SEC |
Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
BEKHealth Corp chose not to state its revenue in its newest notice of a funding round (Oct 2026).
SEC Form D · Oct 2026
The industry group it chose in its notices: Other Technology.
SEC Form D · Oct 2026
That is all the official record says: BEKHealth Corp has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.
Products and services#
No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).
Investors#
No investor of BEKHealth Corp is named in an official source we use. Its funding notices give only how many investors bought, not who they are.
Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 5 rounds above had up to 16 investors.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| David Levin | Executive officer | Sep 2024 |
| Joshua Ransom | Executive officer | Sep 2024 |
| Jason Baumgartner | Executive officer | Feb 2023 |
| B. Bobby Bahram | Director | Oct 2026 |
| Kelly Hollis | Director | Oct 2026 |
| Bobby Bahram | Director | Sep 2024 |
| Christian Burns | Director | Sep 2024 |
| David Levin | Director | Sep 2024 |
| Hugh Roome | Director | Sep 2024 |
| Jeanne Hecht | Director | Sep 2024 |
| John Crumpler | Director | Sep 2024 |
| Jordan Lipson | Director | Sep 2024 |
| Steve Skolsky | Director | Sep 2024 |
| Vickram Pradhan | Director | Sep 2024 |
| Andrew Schwab | Director | Nov 2023 |
| Devin Carty | Director | Nov 2023 |
| Jason Baumgartner | Director | Nov 2023 |